SCHEMBL25524008

SCHEMBL25524008

CC(C)c1ncc(-c2cc(N)c3ccccc3n2)cc1O

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ACHE P22303 1/20 0.56
▸ NCF1 P14598 1/20 0.43
▸ DHODH Q02127 3/20 0.41
▸ TSHR P16473 1/20 0.39
▸ ACACA Q13085 2/20 0.39
▸ TACR3 P29371 2/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ ADORA2A P29274 1/20 0.37
▸ ADORA1 P30542 1/20 0.37
▸ LMNA P02545 3/20 0.37
▸ SMN1; SMN2 Q16637 3/20 0.37
▸ KDM4E B2RXH2 2/20 0.37
▸ HPGD P15428 2/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ PDE10A Q9Y233 1/20 0.37
▸ POLB P06746 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25523537 0.83 ACHE (0.60) ACHENCF1DHODHTSHRTACR3
SCHEMBL25522194 0.79 AR (0.50) CYP1A2LMNASMN1; SMN2KDM4EHPGD
SCHEMBL25524104 0.75 PDGFRB (0.51) CYP1A2LMNASMN1; SMN2KDM4EHPGD
SCHEMBL25522058 0.74 ADORA2A (0.50) ADORA2ALMNASMN1; SMN2NPC1RAB9A
SCHEMBL2873300 0.74 ACHE (1.00) ACHENCF1DHODHACACAADORA2A
SCHEMBL25522191 0.74 NPC1 (0.50) CYP1A2KDM4ENPC1RAB9A
SCHEMBL4155489 0.73 ACHE (0.72) ACHENCF1DHODHACACACYP1A2
SCHEMBL25524007 0.72 PDGFRB (0.40) SMN1; SMN2KDM4EHPGDALDH1A1
SCHEMBL25189022 0.72 RAB9A (0.49) ACHENCF1CYP1A2LMNASMN1; SMN2
SCHEMBL28516025 0.71 ACHE (0.93) ACHENCF1DHODHACACAADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023086428-A2 NOVEL MODULATORS OF THE ARYL HYDROCARBON RECEPTOR AND METHODS OF USE THEREOF ALLIANTHERA (SUZHOU) BIOPHARMACEUTICAL CO., LTD. (CN) 2023-05-19 — — WO disclosed
Send feedback